Pediatric Pain and Palliative Care Program, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States.
Departments of Medicine Statistics Core and.
Pain. 2019 Jun;160(6):1421-1430. doi: 10.1097/j.pain.0000000000001516.
Primary dysmenorrhea (PD; menstrual pain without an underlying medical condition) is associated with enhanced pain sensitivity and temporal summation (TS) in adult women, which may reflect the presence of central pain processes. Research in this area has been limited by focusing on only adult populations and incomplete assessments of central sensitization. The current study explored both excitatory and inhibitory measures of pain processing in girls and young adult women with and without PD. Thirty-two young women with PD and 34 healthy controls underwent laboratory pain testing during each of 3 menstrual cycle phases (menstrual, ovulatory, and midluteal), which included measures of pain tolerance and threshold, TS, and conditioned pain modulation. Results indicated enhanced pain sensitivity in young women with PD as measured by heat pain tolerance and Average Pain50 (P50), compared with healthy controls. These group differences were evident at all phases of the menstrual cycle. No group differences in cold pain tolerance, TS, or conditioned pain modulation were evident at any phase of the menstrual cycle. These data suggest some evidence of central sensitization in young women with PD, although no evidence of enhanced excitatory or deficient inhibitory mechanisms were observed. Future research should focus on identifying other potential phenotypes for PD to determine those at risk of developing other pain problems.
原发性痛经(PD;无潜在医学病症的经期疼痛)与成年女性的疼痛敏感性增强和时间总和(TS)有关,这可能反映了中枢疼痛过程的存在。该领域的研究受到限制,原因是仅关注成年人群体,以及对中枢敏化的评估不完整。本研究在 PD 患者和健康对照者的女孩和年轻成年女性中同时探索了疼痛处理的兴奋和抑制措施。32 名 PD 年轻女性和 34 名健康对照者在每个月经周期的 3 个阶段(月经期、排卵期和黄体中期)接受了实验室疼痛测试,包括疼痛耐量和阈值、TS 和条件性疼痛调制的测量。结果表明,与健康对照组相比,PD 年轻女性的热痛耐量和平均疼痛 50(P50)测量的疼痛敏感性增强。这些组间差异在月经周期的所有阶段都很明显。在月经周期的任何阶段,冷痛耐量、TS 或条件性疼痛调制均无组间差异。这些数据表明 PD 年轻女性存在一定程度的中枢敏化,但未观察到增强的兴奋性或抑制性机制不足的证据。未来的研究应集中于确定 PD 的其他潜在表型,以确定那些有发展其他疼痛问题风险的患者。